Does radiosurgery have a role in the treatment of acromegaly?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 4, Issue 11, 2008, Pages 592-593

  Swearingen, Brooke ^a,b   Loeffler, Jay ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acromegaly; Pituitary; Radiosurgery; Remission; Tumor

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; CANCER SURGERY; DISEASE ACTIVITY; GAMMA KNIFE RADIOSURGERY; HUMAN; HYPOGONADISM; HYPOPITUITARISM; IONIZING RADIATION; NOTE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; STEREOTACTIC RADIOSURGERY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 54549102031     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0948     Document Type: Note

References (7)

1. Losa M et al. (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93: 2546-2552
2. Petit JH et al. (2007) Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 13: 726-734
3. Vik-Mo EO et al. (2007) Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol 157: 255-263
4. Pollock BE et al. (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106: 833-838
5. Castinetti F et al. (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90: 4483-4488
6. Jane JA Jr et al. (2003) Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14: e12
7. Ayuk J et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89: 1613-1617